Sign-up for our e-Bulletin:  
View our archives:   












Questions & Answers

 

Is triple therapy (ACEI+BB+candesartan cilexetil) both effective and safe for patients with heart failure?

Should blood pressure be monitored with candesartan cilexetil treatment?

How should physicians monitor renal function in patients taking candesartan cilexetil? How much of a problem is hyperkalemia, and does it worsen when an ACEI is used together with candesartan cilexetil? Should candesartan cilexetil be avoided in patients with kidney disease?

Are ARBs as effective as ACEIs in heart failure treatment?

Does it make sense to start two drugs at once? If so, which drugs can be safely started together?

Do the results from the CHARM trials reflect a candesartan cilexetil-specific effect or an ARBs class effect?

What are the differences among the available beta blockers? In light of the high costs of drugs, can you use a generic form?

Are there still benefits to using a beta blocker if you are unable to titrate to maximum dose?

Can you use beta blockers in patients with asthma?

Based on COMET, would you say that a non-selective beta blocker is better than a beta-1 selective beta blocker?

How do you manage the side effects of beta blockers (ie, low heart rate, low blood pressure, depression, etc.)?

 

back   ↑back to top